Kees de Joncheere

1.9k total citations · 1 hit paper
23 papers, 1.3k citations indexed

About

Kees de Joncheere is a scholar working on Economics and Econometrics, General Health Professions and Management of Technology and Innovation. According to data from OpenAlex, Kees de Joncheere has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Economics and Econometrics, 8 papers in General Health Professions and 3 papers in Management of Technology and Innovation. Recurrent topics in Kees de Joncheere's work include Pharmaceutical Economics and Policy (18 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Global Health Care Issues (4 papers). Kees de Joncheere is often cited by papers focused on Pharmaceutical Economics and Policy (18 papers), Health Systems, Economic Evaluations, Quality of Life (15 papers) and Global Health Care Issues (4 papers). Kees de Joncheere collaborates with scholars based in Switzerland, Austria and Denmark. Kees de Joncheere's co-authors include Sabine Vogler, Suzanne Hill, Jeremy A. Lauer, Tessa Tan-Torres Edejer, Marie‐Paule Kieny, Melanie Bertram, Raymond Hutubessy, Christine Leopold, Nina Zimmermann and Hubert G. M. Leufkens and has published in prestigious journals such as The Lancet, PLoS Medicine and Bulletin of the World Health Organization.

In The Last Decade

Kees de Joncheere

21 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cost–effectiveness thresholds: pros and cons

2016 525 citations Melanie Bertram, Jeremy A. Lauer et al. Bulletin of the World Health Organization profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kees de Joncheere Switzerland	14	787	217	190	151	131	23	1.3k
Ruth Lopert Australia	18	605 0.8×	255 1.2×	62 0.3×	122 0.8×	33 0.3×	49	1.1k
Beth Woods United Kingdom	15	370 0.5×	187 0.9×	179 0.9×	130 0.9×	49 0.4×	59	1.5k
John Kyriopoulos Greece	18	408 0.5×	538 2.5×	139 0.7×	105 0.7×	19 0.1×	135	1.4k
Marco Barbieri United Kingdom	14	524 0.7×	247 1.1×	125 0.7×	84 0.6×	24 0.2×	34	1.1k
Robert S. Woodward United States	25	240 0.3×	206 0.9×	375 2.0×	123 0.8×	98 0.7×	73	2.3k
Ahmed Al‐Jedai Saudi Arabia	20	120 0.2×	90 0.4×	157 0.8×	101 0.7×	93 0.7×	106	950
B. Martin van Ineveld Netherlands	16	741 0.9×	519 2.4×	231 1.2×	70 0.5×	36 0.3×	24	2.1k
Beate Jahn Austria	19	491 0.6×	223 1.0×	210 1.1×	94 0.6×	44 0.3×	75	1.5k
Sitaporn Youngkong Thailand	17	417 0.5×	201 0.9×	79 0.4×	133 0.9×	20 0.2×	54	800
Mark Nuijten Netherlands	12	487 0.6×	199 0.9×	102 0.5×	62 0.4×	22 0.2×	44	954

Countries citing papers authored by Kees de Joncheere

Since Specialization

Citations

This map shows the geographic impact of Kees de Joncheere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kees de Joncheere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kees de Joncheere more than expected).

Fields of papers citing papers by Kees de Joncheere

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kees de Joncheere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kees de Joncheere. The network helps show where Kees de Joncheere may publish in the future.

Co-authorship network of co-authors of Kees de Joncheere

This figure shows the co-authorship network connecting the top 25 collaborators of Kees de Joncheere. A scholar is included among the top collaborators of Kees de Joncheere based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kees de Joncheere. Kees de Joncheere is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gray, Andy, et al.. (2019). Patent pooling to increase access to essential medicines. Bulletin of the World Health Organization. 97(8). 575–577. 32 indexed citations

Vogler, Sabine, Valérie Paris, Alessandra Ferrario, et al.. (2017). How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries. Applied Health Economics and Health Policy. 15(3). 307–321. 117 indexed citations

Vogler, Sabine, Nina Zimmermann, Alessandra Ferrario, et al.. (2016). Pharmaceutical policies in a crisis? Challenges and solutions identified at the PPRI Conference. Journal of Pharmaceutical Policy and Practice. 9(1). 9–9. 8 indexed citations

Vogler, Sabine, Nina Zimmermann, & Kees de Joncheere. (2016). Policy interventions related to medicines: Survey of measures taken in European countries during 2010–2015. Health Policy. 120(12). 1363–1377. 32 indexed citations

Bertram, Melanie, Jeremy A. Lauer, Kees de Joncheere, et al.. (2016). Cost–effectiveness thresholds: pros and cons. Bulletin of the World Health Organization. 94(12). 925–930. 525 indexed citations breakdown →

Tay-Teo, Kiu, Sabine Vogler, Peter Beyer, et al.. (2016). Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis. PLoS Medicine. 13(5). e1002032–e1002032. 172 indexed citations

Robertson, Jane, Cécile Macé, Gilles Forte, Kees de Joncheere, & David Beran. (2015). Medicines availability for non-communicable diseases: the case for standardized monitoring. Globalization and Health. 11(1). 18–18. 36 indexed citations

Vogler, Sabine, Nina Zimmermann, & Kees de Joncheere. (2015). The Pharmaceutical Pricing and Reimbursement Information (PPRI) network – a decade of exchange of information and policy research?. Journal of Pharmaceutical Policy and Practice. 8(S1). 4 indexed citations

Magrini, Nicola, Jane Robertson, Gilles Forte, et al.. (2015). Tough decisions on essential medicines in 2015. Bulletin of the World Health Organization. 93(4). 283–284. 18 indexed citations

10.

Leopold, Christine, Aukje K. Mantel‐Teeuwisse, Sabine Vogler, et al.. (2014). Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries. Bulletin of the World Health Organization. 92(9). 630–640D. 34 indexed citations

11.

Leopold, Christine, et al.. (2013). Is Europe still heading to a common price level for on-patent medicines? An exploratory study among 15 Western European countries. Health Policy. 112(3). 209–216. 23 indexed citations

12.

Leopold, Christine, Leonhard Seyfang, Sabine Vogler, et al.. (2012). Impact of external price referencing on medicine prices - a price comparison among 14 European countries.. PubMed. 5(2). 34–41. 34 indexed citations

13.

Vogler, Sabine, Nina Zimmermann, Christine Leopold, & Kees de Joncheere. (2011). Pharmaceutical policies in European countries in response to the global financial crisis. PubMed. 4(2). 69–79. 106 indexed citations

14.

Leopold, Christine, et al.. (2011). Differences in external price referencing in Europe—A descriptive overview. Health Policy. 104(1). 50–60. 88 indexed citations

15.

Kanavos, Panos, Sotiris Vandoros, Jarno Habicht, & Kees de Joncheere. (2009). Review of the Estonian pharmaceutical sector: towards the development of a national medicines policy. London School of Economics and Political Science Research Online (London School of Economics and Political Science). 7 indexed citations

16.

Joncheere, Kees de, et al.. (2002). Scope of the problem. International Journal of Risk & Safety in Medicine. 15(1-2). 7–13.

17.

Joncheere, Kees de, et al.. (2002). Providing affordable medicines in transitional countries. International Journal of Risk & Safety in Medicine. 15(1-2). 127–135. 3 indexed citations

18.

Joncheere, Kees de, et al.. (2002). Experiences with generics. International Journal of Risk & Safety in Medicine. 15(1-2). 101–109. 5 indexed citations

19.

Freemantle, Nick, et al.. (2001). Pricing and reimbursement of pharmaceuticals in the Baltic States. The Lancet. 358(9278). 260–260. 6 indexed citations

20.

Joncheere, Kees de. (2001). The Role of the World Health Organization on Pharmaceuticals in Europe. Value in Health. 4(3). 217–224. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact